Molecular insights into peptide agonist engagement with the PTH receptor.

[1]  Zhihong Liu,et al.  Molecular insights into the distinct signaling duration for the peptide-induced PTH1R activation , 2022, Nature Communications.

[2]  Xinheng He,et al.  Molecular recognition of two endogenous hormones by the human parathyroid hormone receptor-1 , 2022, bioRxiv.

[3]  Hideaki E. Kato,et al.  Endogenous ligand recognition and structural transition of a human PTH receptor. , 2022, Molecular cell.

[4]  S. Gellman,et al.  Kinetic and Thermodynamic Insights on Agonist Interactions with the Parathyroid Hormone Receptor-1 from a New NanoBRET assay , 2022, bioRxiv.

[5]  P. Sexton,et al.  A structural basis for amylin receptor phenotype , 2022, Science.

[6]  H. Xu,et al.  Structural perspective of class B1 GPCR signaling. , 2022, Trends in pharmacological sciences.

[7]  J. Chiorini,et al.  Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor. , 2021, New England Journal of Medicine.

[8]  I. Bahar,et al.  Spatial bias in cAMP generation determines biological responses to PTH type 1 receptor activation , 2021, Science Signaling.

[9]  C. Langmead,et al.  Cryo-EM structure of the dual incretin receptor agonist, peptide-19, in complex with the glucagon-like peptide-1 receptor. , 2021, Biochemical and biophysical research communications.

[10]  Hualiang Jiang,et al.  Constitutive signal bias mediated by the human GHRHR splice variant 1 , 2021, Proceedings of the National Academy of Sciences.

[11]  P. Sexton,et al.  Structure and dynamics of semaglutide- and taspoglutide-bound GLP-1R-Gs complexes. , 2021, Cell reports.

[12]  K. Gregory,et al.  Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation , 2021, bioRxiv.

[13]  P. Sexton,et al.  Structural and Functional Diversity among Agonist-Bound States of the GLP-1 Receptor , 2021, bioRxiv.

[14]  David J. Fleet,et al.  3D Variability Analysis: Resolving continuous flexibility and discrete heterogeneity from single particle cryo-EM. , 2021, Journal of structural biology.

[15]  T. Martin,et al.  Physiological and Pharmacological Roles of PTH and PTHrP in Bone using their Shared Receptor, PTH1R. , 2021, Endocrine reviews.

[16]  Marc N. Wein,et al.  Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long‐Acting PTH , 2020, JBMR plus.

[17]  M. Rosenkilde,et al.  A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor , 2020, Cell Research.

[18]  C. Langmead,et al.  Differential GLP-1R Binding and Activation by Peptide and Non-peptide Agonists. , 2020, Molecular cell.

[19]  T. Gardella,et al.  Optimization of PTH/PTHrP Hybrid Peptides to Derive a Long‐Acting PTH Analog (LA‐PTH) , 2020, JBMR plus.

[20]  John D. McCorvy,et al.  “TRUPATH, an Open-Source Biosensor Platform for Interrogating the GPCR Transducerome” , 2020, Nature Chemical Biology.

[21]  Randy J. Read,et al.  Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix , 2019, Acta crystallographica. Section D, Structural biology.

[22]  Tomoyuki Watanabe,et al.  Structure and dynamics of the active human parathyroid hormone receptor-1 , 2019, Science.

[23]  A. J. Venkatakrishnan,et al.  Diverse GPCRs exhibit conserved water networks for stabilization and activation , 2019, Proceedings of the National Academy of Sciences.

[24]  Thorsten Wagner,et al.  SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM , 2019, Communications Biology.

[25]  Erik Lindahl,et al.  New tools for automated high-resolution cryo-EM structure determination in RELION-3 , 2018, eLife.

[26]  A. Plückthun,et al.  High-resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist , 2018, Nature Structural & Molecular Biology.

[27]  Jasenko Zivanov,et al.  A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis , 2018, bioRxiv.

[28]  Arthur Christopoulos,et al.  Dominant Negative G Proteins Enhance Formation and Purification of Agonist-GPCR-G Protein Complexes for Structure Determination. , 2018, ACS pharmacology & translational science.

[29]  Tristan Ian Croll,et al.  ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps , 2018, Acta crystallographica. Section D, Structural biology.

[30]  Conrad C. Huang,et al.  UCSF ChimeraX: Meeting modern challenges in visualization and analysis , 2018, Protein science : a publication of the Protein Society.

[31]  R. Stevens,et al.  Extending the Structural View of Class B GPCRs. , 2017, Trends in biochemical sciences.

[32]  Arthur Christopoulos,et al.  Phase-plate cryo-EM structure of a class B GPCR-G protein complex , 2017, Nature.

[33]  D. Agard,et al.  MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy , 2017, Nature Methods.

[34]  David J. Fleet,et al.  cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination , 2017, Nature Methods.

[35]  C. Russo,et al.  Ultrastable gold substrates: Properties of a support for high-resolution electron cryomicroscopy of biological specimens , 2016, Journal of structural biology.

[36]  T. Gardella,et al.  Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling. , 2016, Endocrinology.

[37]  Samuel H. Gellman,et al.  PTH receptor-1 signalling—mechanistic insights and therapeutic prospects , 2015, Nature Reviews Endocrinology.

[38]  N. Grigorieff,et al.  CTFFIND4: Fast and accurate defocus estimation from electron micrographs , 2015, bioRxiv.

[39]  Clinton S Potter,et al.  Conformational states of the full-length glucagon receptor , 2015, Nature Communications.

[40]  Esther S. Kim,et al.  Recombinant Human Parathyroid Hormone (1–84): A Review in Hypoparathyroidism , 2015, Drugs.

[41]  Kai Zhang,et al.  Gctf: Real-time CTF determination and correction , 2015, bioRxiv.

[42]  J. Zanchetta,et al.  Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis. , 2015, The Journal of clinical endocrinology and metabolism.

[43]  B. Spiegelman,et al.  Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia , 2014, Nature.

[44]  Arthur Christopoulos,et al.  Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations , 2013, Proceedings of the National Academy of Sciences.

[45]  Roman A. Laskowski,et al.  LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery , 2011, J. Chem. Inf. Model..

[46]  S. Rasmussen,et al.  Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.

[47]  T. Gardella,et al.  Retromer terminates the generation of cAMP by internalized PTH-receptors , 2011, Nature chemical biology.

[48]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[49]  L. Miller,et al.  Dimeric Arrangement of the Parathyroid Hormone Receptor and a Structural Mechanism for Ligand-induced Dissociation* , 2010, The Journal of Biological Chemistry.

[50]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[51]  Bin Wang,et al.  Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. , 2009, Nature chemical biology.

[52]  H. Xu,et al.  Structural Basis for Parathyroid Hormone-related Protein Binding to the Parathyroid Hormone Receptor and Design of Conformation-selective Peptides* , 2009, The Journal of Biological Chemistry.

[53]  M. Bouxsein,et al.  Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation , 2008, Proceedings of the National Academy of Sciences.

[54]  H. Xu,et al.  Molecular recognition of parathyroid hormone by its G protein-coupled receptor , 2008, Proceedings of the National Academy of Sciences.

[55]  T. Gardella,et al.  Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor. , 2008, Molecular endocrinology.

[56]  D. Decamp,et al.  Use of a cAMP BRET Sensor to Characterize a Novel Regulation of cAMP by the Sphingosine 1-Phosphate/G13 Pathway* , 2007, Journal of Biological Chemistry.

[57]  H. Jüppner,et al.  Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations. , 2006, Molecular endocrinology.

[58]  M. Lohse,et al.  Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[59]  T. Gardella,et al.  Parathyroid Hormone (PTH)-(1–14) and -(1–11) Analogs Conformationally Constrained by α-Aminoisobutyric Acid Mediate Full Agonist Responses via the Juxtamembrane Region of the PTH-1 Receptor* , 2001, The Journal of Biological Chemistry.

[60]  T. Gardella,et al.  Enhanced activity in parathyroid hormone-(1-14) and -(1-11): novel peptides for probing ligand-receptor interactions. , 2001, Endocrinology.

[61]  T. Gardella,et al.  The (1-14) fragment of parathyroid hormone (PTH) activates intact and amino-terminally truncated PTH-1 receptors. , 1999, Molecular endocrinology.

[62]  A. Parfitt,et al.  Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. , 1996, The New England journal of medicine.